Page last updated: 2024-09-02

fr 139317 and candesartan cilexetil

fr 139317 has been researched along with candesartan cilexetil in 1 studies

Study Comparison

Studies
(fr 139317)
Trials
(fr 139317)
Recent Studies (post-2010)
(fr 139317)
Studies
(candesartan cilexetil)
Trials
(candesartan cilexetil)
Recent Studies (post-2010)
(candesartan cilexetil)
21908628151133

Protein Interaction Comparison

ProteinTaxonomyfr 139317 (IC50)candesartan cilexetil (IC50)
Type-1 angiotensin II receptorOryctolagus cuniculus (rabbit)0.2
Solute carrier organic anion transporter family member 1B3Homo sapiens (human)2.4547
DNA polymerase kappaHomo sapiens (human)7.4
DNA polymerase iotaHomo sapiens (human)6.2
Broad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)5
Solute carrier organic anion transporter family member 1B1Homo sapiens (human)0.7244

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Knoshita, M; Wada, A1

Reviews

1 review(s) available for fr 139317 and candesartan cilexetil

ArticleYear
[Disorders of body water regulation and the therapy--role of atrial natriuretic peptide in homeostasis of body water in heart failure].
    Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 1997, Sep-10, Volume: 86, Issue:9

    Topics: Angiotensin Receptor Antagonists; Animals; Atrial Natriuretic Factor; Azepines; Benzimidazoles; Biphenyl Compounds; Body Water; Down-Regulation; Endothelin Receptor Antagonists; Heart Failure; Homeostasis; Humans; Indoles; Peptides, Cyclic; Receptor, Endothelin A; Receptor, Endothelin B; Receptors, Atrial Natriuretic Factor; Sodium; Tetrazoles

1997